TransMedics Group, Inc. (TMDX) Stock Analysis

Not Halal Healthcare
Price $68.94
Market Cap $3.44B

Is TMDX a good investment?

TransMedics Group, Inc. (TMDX) has a Plutrex AI rating of pending review as of May 26, 2026, indicating a pending review consensus. The stock is not classified as halal-compliant.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is TMDX a halal stock?

No, TransMedics Group, Inc. (TMDX) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for TMDX?

TransMedics Group, Inc. (TMDX) has a Plutrex AI rating of pending review with a pending review consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is TMDX a good investment?

According to Plutrex AI, TMDX has a pending review rating (pending review). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in TMDX?

US stocks like TMDX can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in TMDX?

Plutrex AI identifies the main risks for TMDX by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with Plutrex AI about TMDX

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open TMDX in Plutrex